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Abstract
Polyglutamine expansion causes the disease proteins to aggregate, resulting in stable insoluble aggregates in the nucleus.
The in vitro aggregation and cellular toxicity of polyglutamine proteins are reduced by chaperone heat shock proteins (Hsp).
In polyglutamine disease animal models, however, polyglutamine inclusions remain in the nucleus despite the suppression of
neurodegeneration by Hsp. Studies using yeast genetic approach revealed that the balance of Hsp is important for regulating
protein aggregation in the cytoplasm of yeast cells. Here we report that N-terminal fragments of huntingtin with an expanded
polyglutamine tract form aggregates only in the cytoplasm of yeast cells and, when tagged with nuclear localization sequences
(NLS), are able to aggregate in the nucleus. Deletion of the Hsp104 gene prevents the aggregation of huntingtin in the
cytoplasm but is unable to eliminate the aggregation of NLS-tagged huntingtin in the nucleus. The inhibitory effect of
Hsp104 deletion on the cytoplasmic aggregation of huntingtin only occurs in viable yeast cells, as aggregates can be formed in
Hsp104 deletion cells that have been frozen for 72 h. Fresh cytosolic extracts of the Hsp104 deletion strain inhibit the
aggregation of huntingtin in vitro, suggesting that the deletion of Hsp104 may alter the activities of other cytoplasmic factors
to inhibit polyglutamine aggregation in the cytoplasm. We propose that the regulatory effects of chaperones may mainly be
restricted to the cytoplasm and have much less influence on polyglutamine-containing aggregates in the nucleus. ß 2001
Elsevier Science B.V. All rights reserved.
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1. Introduction
Eight inherited neurodegenerative disorders, in-
cluding Huntington’s disease (HD), are caused by
polyglutamine expansion in the associated disease
proteins [1]. The HD protein huntingtin, a 350 kDa
protein of unknown function, contains a glutamine
repeat in its N-terminal region and induces neuro-
degeneration when the repeat contains more than
37 glutamines [2]. A common feature of polyglut-
amine diseases is that polyglutamine expansion
causes the disease proteins to aggregate in vitro
and in vivo [1]. The most striking evidence is that
N-terminal fragments of huntingtin form large intra-
nuclear aggregates in the brain [3^7] and cause pro-
gressive neurological phenotypes in HD transgenic
mice [4]. Although it remains unclear whether poly-
glutamine aggregates are pathologically causative,
these aggregates certainly represent a pathological
event associated with polyglutamine expansion.
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Thus, the study of the regulation of polyglutamine
aggregates by cellular factors may provide insight
into the pathogenesis of polyglutamine disorders.
N-Terminal huntingtin fragments are able to form
aggregates in both the cytoplasm and nucleus in HD
transgenic mice [4,6,7]. Nuclear aggregates appear
much earlier and are more abundant than cytoplas-
mic aggregates in presymptomatic HD mice [6,7].
Similarly, examining the brain of patients with HD
revealed that most large huntingtin aggregates are
preserved in the nucleus, whereas small aggregates
are present in the cytoplasm or neuronal processes
[4,5]. However, huntingtin with expanded polyglut-
amine tracts can self-aggregate in the test tubes
even in the absence of cellular contents [8]. These
¢ndings suggest that polyglutamine-containing pro-
teins may form aggregates preferentially in the nu-
cleus and that cytoplasmic environments may not
favor polyglutamine aggregation.
The ubiquitin degradation pathway and molecular
chaperones, particularly heat shock proteins, have
been recently found to inhibit the aggregation of
polyglutamine proteins [9^17]. The ubiquitin-protea-
some pathway is important for the degradation of
polyglutamine proteins, and this degradation may
slow the progression of polyglutamine diseases. Sev-
eral chaperone proteins have also been found to co-
localize with polyglutamine-containing aggregates [9^
17]. Since chaperones maintain proteins in appropri-
ate conformations [18], they may be more important
than proteasomes in preventing polyglutamine aggre-
gation. Indeed, recent studies have demonstrated that
overexpression of chaperones reduces polyglutamine-
mediated cellular toxicity and aggregates in cultured
cells [9^17]. However, overexpression of chaperones
does not a¡ect nuclear inclusions in Drosophila de-
spite its protective e¡ects on neurodegeneration
[19,20]. To add to the complexity, one study showed
that overexpression of some heat shock proteins
(HDJ-2/HSDJ) can increase the formation of poly-
glutamine aggregates in Cos-7 cells [21]. While the
balance of chaperones is believed to be critical for
their regulation of polyglutamine aggregates [21], the
e¡ect of chaperones on nuclear aggregation of poly-
glutamine proteins is still unknown.
Given that chaperones can prevent neurodegener-
ation in polyglutamine animal models [19,20], it is
important to investigate whether chaperones a¡ect
nuclear polyglutamine aggregation, a common
pathological phenomenon present in glutamine re-
peat disorders. We hypothesized that the e¡ects of
chaperones on polyglutamine aggregates might be
di¡erent in the cytoplasm and in the nucleus. To
test this idea, we used yeast, a eukaryotic model sys-
tem in which protein expression can be genetically
manipulated, to study the e¡ect of chaperone protein
Hsp104 on the aggregation of huntingtin in the cy-
toplasm and nucleus. While the deletion of Hsp104
gene inhibits the aggregation of huntingtin in the
cytoplasm, it does not prevent huntingtin aggrega-
tion in the nucleus. We propose that the regulatory
e¡ect of chaperones on polyglutamine aggregation is
restricted to the cytoplasm and has much less in£u-
ence on aggregates in the nucleus.
2. Materials and methods
2.1. DNA constructs
Green £uorescent protein (GFP) was fused in-
frame into the N-terminus of the HD exon1 protein
containing 120 or 20 glutamines using the yeast GFP
expression vector pPS808 (provided by A. Corbett,
Emory University). This vector contains a URA3 se-
lection marker and the GAL10 promoter followed by
GFP. The HD exon1 protein without the GFP tag
was constructed in the LMY2.9 yeast vector (pro-
vided by Dr. Fridovich-Keil, Emory University).
This vector contains a GAL10 promoter and a
TRP1 selection marker. Synthesized double strand
oligonucleotides (CG GGA TCC CCA AAG AAG
AAG CGA AAG GTA GGA TCC AC) that encode
nuclear localization sequences (PKKKRKV) were in-
serted in-frame between GFP and the N-terminal
fragment of the HD exon1 protein using the BamHI
site in the yeast vector pPS808. To assess the e¡ects
of yeast extracts on the aggregation of huntingtin, we
tagged His epitope to the C-terminus of the HD
exon1 proteins with 120 glutamines using the pET-
28a vector (Novagen).
2.2. Yeast strains, transformation, and culture
Wild type yeast strain YPH499 (MATa ade2-
101ochre his3-v200 leu2-v1 lys2-801amber trp-v63
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ura3-52) and mutant yeast strains with deletion of
the gene for Hsp104 (YDHd104) were provided by
Dr. S. Lindquist (University of Chicago). Transfor-
mation of yeast was performed using a standard lith-
ium/polyethylene glycol method [22].
An overnight culture of yeast was used to inocu-
late ra⁄nose minimal medium lacking uracil. Cells
were than pelleted and washed before adding in ga-
lactose and minimal medium lacking uracil to induce
the expression of huntingtin. The concentrations of
yeast cells were adjusted to OD600 = 0.1 for batch
culture in 50 ml of medium. Aliquots (2 ml) were
taken at various time points and the OD600 was de-
termined. The growth rate was also assessed by plat-
ing yeast and counting the number of colonies.
2.3. Western blots and ¢lter trap assay
Western blots were performed using the antibody
EM48 that is speci¢c to the N-terminal region of
huntingtin [5]. Yeast extracts were prepared using
glass bead disruption and resuspended in PBS. For
¢lter trap assays, the pellet fraction (13 000Ug for
10 min) of the disrupted yeast was treated with 2%
SDS at room temperature for 15 min, sonicated for
10 s, and ¢ltered through a cellulose acetate mem-
brane (Schleicher and Schuell, 0.2 Wm pore size). A
dot blot ¢ltration unit was used for ¢lter trap assays.
The SDS-insoluble aggregates that were retained on
the ¢lters were detected by incubation with EM48,
followed by ECL detection [8].
2.4. In vitro inhibition of huntingtin aggregation
His-huntingtin proteins were produced in bacterial
strain BL21. Bacterial lysates in PBS/0.5% Triton
X-100 containing His-huntingtin were pre¢ltered
through a 0.20 Wm syringe ¢lter and incubated with
yeast extracts or controls at 4‡C overnight for self-
aggregation. Yeast extracts were prepared from wild
type and the Hsp104 deletion strain using glass bead
disruption and high speed centrifugation (13 000Ug
for 15 min). One volume of yeast cytosolic extracts
(0.5 Wg protein/Wl) was incubated with 1 vol. of His-
huntingtin transformed bacterial lysates (0.5 Wg pro-
tein/Wl). Aliquots of the incubations were taken
every day and stored at 380‡C. After 3 days, all
aliquots of the incubations were subjected to ¢lter
trap assay. His-huntingtin incubated with PBS alone,
bovine serum albumin (BSA) (0.5 Wg protein/Wl)
or boiled yeast extracts was used as control. Densi-
tometry was used to quantify the intensity of the
immunoreactive products retained on the ¢lter using
a Personal Densitometer S1 (Molecular Dynamics,
Eugene, OR). All values were expressed as mean
þ S.D. Statistical signi¢cance was assessed by the
use of Student’s t-test. P6 0.05 was considered sig-
ni¢cant.
2.5. Fluorescence microscopy
Yeast cells were seeded onto glass coverslips. The
growing cells were stained with 4P,6-diamidino-2-
phenylindole dihydrochloride (DAPI, Sigma) for 1 h
to reveal the nucleus. Cells were then examined with
a Zeiss £uorescent microscope (Axioskop 2) and op-
tical ¢lters to visualize GFP and the nucleus. Micro-
graphs were taken at 100U magni¢cation with a vid-
eo system (Dage-MTI, Michigan City, IN). The
images were processed using Adobe Photoshop soft-
ware. For EM48 immunostaining, yeast cells were
¢xed in 4% paraformaldehyde in PBS for 15 min,
digested with 5 U/ml zymolyase 20T (ICN Biochem-
icals), permeabilized with 0.4% Triton X-100 in PBS
for 30 min, blocked with 5% normal goat serum
(NGS) in PBS for 1 h, and incubated with primary
antibodies in 2% NGS/PBS overnight at 4‡C.
3. Results
3.1. Expanded huntingtin forms aggregates in the
cytoplasm of yeast
The HD exon1 protein (the ¢rst 67 amino acids)
with an expanded glutamine repeat (115^150 gluta-
mines) is able to form intranuclear aggregates in HD
transgenic mice [3]. Also, this protein accumulates in
the nucleus of stably transfected PC12 cells [23].
When expressed in yeast, the HD exon1 protein
with 150 glutamine repeats (150Q) forms aggregates,
whereas the HD exon1 protein with a normal gluta-
mine repeat (23Q) does not (Fig. 1). However, the
majority of the transfected 150Q protein and its ag-
gregates are in the cytoplasm. The inability of the
150Q protein to form nuclear aggregates in yeast
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suggests that speci¢c mammalian proteins may be
required for mutant huntingtin to enter the nucleus.
To directly visualize huntingtin aggregates in living
yeast, we tagged GFP to the N-terminus of the HD
exon1 protein containing 120 (GFP-120Q) or 20
(GFP-20Q) glutamines in the repeat. Fluorescent mi-
croscopy revealed that the GFP-120Q protein and its
aggregates are also localized in the cytoplasm of
yeast cells (see below).
3.2. Expression of nuclear localization signal (NLS)-
huntingtin in the nucleus of yeast
Examining growth rate and morphology did not
reveal any signi¢cant di¡erence between yeast cells
expressing mutant huntingtin and those expressing
normal huntingtin. Despite this, these yeast cells al-
low us to examine the e¡ect of chaperones on hun-
tingtin aggregation. Recent studies show that yeast
cells lacking the Hsp104 gene do not display any
cytoplasmic aggregates, whereas strains with the de-
letion of Ydj1 (a member of the Hsp40 family) and
Ssa1 (a member of the Hsp70 family) do [21]. It is
unknown whether the e¡ect of Hsp104 deletion is
speci¢c to the cytoplasmic aggregation of huntingtin.
To address this issue, we tagged the GFP-huntingtin
proteins with an NLS so that the expressed hunting-
tin (GFP-NLS-120Q and GFP-NLS-20Q) can be lo-
calized in the nucleus. As expected, the GFP-120Q
without NLS is di¡use in the cytoplasm in Hsp104
deletion cells, in contrast to its aggregation in wild
type yeast cells (Fig. 2). When tagged with NLS, the
Fig. 2. Expression of NLS-tagged huntingtin in the nucleus in
yeast. GFP-120Q (120Q) was transformed into Hsp104 deletion
yeast strain (1043) or wild type yeast (WT). Note that GFP-
120Q forms cytoplasmic aggregates only in wild type yeast cells
(upper panel). When the same GFP-120Q protein was tagged
with NLS (NLS-120Q), it was localized in the nucleus (middle
panel). NLS-tagged GFP-20Q (NLS-20Q) proteins are also lo-
calized in the nucleus, but most of them are still distributed in
the cytoplasm (lower panel). The nucleus was indicated by
DAPI staining, whereas GFP-huntingtin was visualized by £uo-
rescence microscopy.
Fig. 1. Cytoplasmic aggregation of HD exon1 protein with an
expanded glutamine repeat in yeast. Yeast cells were trans-
formed with the HD exon1 protein (the ¢rst 67 amino acids)
containing 23 (23Q) (upper panel) and 150 (150Q) (lower panel)
glutamines. Cells were stained with the antibody EM48 (hun-
tingtin staining) and the nuclear dye DAPI (nuclear staining).
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huntingtin fusion protein (GFP-NLS-120Q) was al-
most exclusively localized in the nucleus. Interest-
ingly, the same fusion protein with 20 glutamine re-
peats (GFP-NLS-20Q) was fairly di¡use throughout
the cells with some intense GFP signal in the nucleus
(Fig. 2). Thus, the extent of intranuclear localization
is apparently dependent on the length of the gluta-
mine repeat.
3.3. Hsp104 deletion does not prevent huntingtin
aggregation in the nucleus
Because of the intense GFP signals in the nucleus,
it was di⁄cult to de¢ne whether GFP-NLS-120Q
forms aggregates in the nucleus using £uorescence
microscopy. Aggregated huntingtin can be detected
by Western blots as immunoreactive products that
remain in the stacking gel [8]. Huntingtin with ex-
panded polyglutamine tracts appears to be not stable
in yeast, resulting in smear bands of soluble mutant
huntingtin on the Western blots (Fig. 3A). Despite
this, GFP-120Q forms aggregated proteins in wild
type yeast cells, but not in Hsp104 deletion strain
(Fig. 3A). When the mutant huntingtin was tagged
with NLS and expressed in the nucleus of Hsp104
deletion cells, however, it forms similar aggregated
proteins seen in the stacking gel. The formation of
aggregates is dependent on the length of polyglut-
amine repeat, as the same huntingtin fragment con-
taining 20 glutamine repeats (GFP-NLS-20Q) did
not show any immunoreactive products in the stack-
ing gel (Fig. 3A). The ¢lter trap assay is another
approach to detect huntingtin aggregates, which are
unable to pass through a cellulose acetate membrane
and are thus retained on the membrane [8]. Using
this assay, we observed that GFP-NLS-120Q in
Hsp104 deletion cells formed aggregates that were
retained on the membrane (Fig. 3B). In contrast,
the GFP-120Q without NLS, when expressed in the
cytoplasm in Hsp104 deletion cells, did not form ag-
gregates. However, this protein was able to aggregate
in wild type yeast cells (Fig. 3B).
3.4. Prevention of huntingtin aggregation by Hsp104
deletion occurs only in viable yeast cells
The e¡ect of Hsp104 deletion on cytoplasmic hun-
tingtin aggregation may result from the alteration of
the activity of other cytoplasmic proteins, which in
turn inhibits huntingtin aggregation. If so, the nor-
mal activity of cellular proteins would be critical for
preventing mutant huntingtin from forming aggre-
Fig. 3. Deletion of Hsp104 does not prevent the aggregation of
huntingtin in the nucleus. (A) The GFP-120Q and NLS-tagged
huntingtin proteins were expressed in wild type (WT) or
Hsp104 deletion (1043) strains. Western blots show that GFP-
NLS-120Q protein (NLS-120Q) forms aggregates in Hsp104 de-
letion strain. Similarly, GFP-120Q (120Q) protein forms aggre-
gates in wild type yeast cells. Neither GFP-120Q without NLS
nor the GFP-NLS-20Q (NLS-20Q) protein forms aggregates in
Hsp104 deletion cells. Aggregated proteins in the stacking gel
are indicated by the arrow. (B) Filter trap assay showing that
GFP-NLS-120Q (NLS-120Q) in Hsp104 deletion strain and
GFP-120Q (120Q) in wild type yeast are able to form aggre-
gated protein on the cellulose acetate membrane. However, the
120Q protein without NLS in the Hsp104 deletion strain was
unable to form aggregates.
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gates in the absence of Hsp104 protein. To test this
hypothesis, we let Hsp104 deletion strain that ex-
presses GFP-120Q stay in 380‡C for 72 h and then
examined the cells for formation of aggregates. Dur-
ing freezing, the expression and activity of most pro-
teins are inhibited. Examining these frozen yeast cells
revealed that a number of cytoplasmic aggregates
had formed in Hsp104 deletion strain (Fig. 4).
Thus, the activity and expression of cellular proteins
seem to be important for the inhibition of huntingtin
aggregates by the deletion of the Hsp104 gene.
3.5. Extracts of Hsp104 deletion strain inhibit
huntingtin aggregation in vitro
It is possible that other cytoplasmic chaperones or
molecules may be activated to inhibit huntingtin ag-
gregation in yeast cells that lack Hsp104 protein. If
so, yeast extracts from the Hsp104 deletion strain
may be able to inhibit the aggregation of recombi-
nant huntingtin in vitro. We therefore prepared cy-
tosolic extracts from wild type and Hsp104 deletion
strains and incubated the extracts with His-tagged
huntingtin proteins that contain the HD exon1 pro-
tein with 120 glutamines (His-120Q). The His-120Q
protein is able to self-aggregate in vitro (Fig. 5A),
allowing us to examine whether the extracts of
Hsp104 deletion cells can inhibit huntingtin aggrega-
tion. To examine whether the e¡ect is speci¢c to the
activity of proteins in the extracts, we also incubated
the His-120Q protein with BSA or yeast extracts that
were boiled to inactivate proteins. We found that
His-120Q formed aggregates more rapidly after incu-
bation with PBS bu¡er, BSA or boiled yeast extracts
than with wild type yeast extracts, suggesting that
yeast extracts contain inhibitory factors that are
heat labile (Fig. 5B). More importantly, the extracts
from the Hsp104 deletion strain inhibited the
aggregation of His-tagged huntingtin to a signi¢-
cantly greater degree, which is most obvious after
1 day incubation. After prolonged incubation (2 and
3 days), the inhibitory e¡ect of the yeast extracts
signi¢cantly decreased. This phenomenon was con-
¢rmed by repeating several independent experiments
and quantifying huntingtin aggregation using the ¢l-
ter trap assay (Fig. 5C). Thus, the results suggest that
the inhibition of huntingtin aggregation is associated
with the activity of proteins in yeast cytosolic ex-
tracts, and this activity is higher in Hsp104 deletion
strain than in wild type yeast cells.
4. Discussion
The present study demonstrates that once hunting-
tin is forced into the nucleus by an NLS epitope, its
aggregation in the nucleus is not prevented by the
deletion of Hsp104. Our ¢ndings suggest that the
e¡ect of chaperones on polyglutamine aggregation
may be restricted to the cytoplasm, which may in
part explain why polyglutamine inclusions are usu-
ally better preserved in the nucleus.
GFP-huntingtin fusion proteins containing ex-
panded polyglutamine repeats are found to localize
Fig. 4. Huntingtin forms aggregates in Hsp104 deletion yeast cells that have been frozen for 72 h. Fluorescence microscopic examina-
tion of GFP-120Q transformed Hsp104 deletion cells reveals that the viable yeast cells (before freezing) show di¡use cytoplasmic £uo-
rescence whereas cells that have been frozen at 380‡C for 72 h (after freezing) display multiple aggregates (arrows) in the cytoplasm.
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in the cytoplasm of yeast cells. The fact that trans-
formed huntingtin is not concentrated in the yeast
nucleus could be explained by several possibilities.
One is that the rapid cell division in yeast prevents
the nuclear accumulation of huntingtin. The second
is that the ultrastructural structure of the nuclear
pore or nuclear environment in yeast is not favorable
for the nuclear translocation of huntingtin. The third
is that yeast cells lack proper transporters to move
huntingtin into the nucleus. Since NLS tagging al-
lows huntingtin to get into the nuclei, it appears
likely that yeast cells lack proteins that transport
N-terminal fragments of huntingtin into the nucleus.
However, huntingtin with a normal glutamine repeat
(GFP-NLS-20Q) remains in the cytoplasm even with
NLS tagging. Thus, GFP-NLS-120Q accumulates
and aggregates in the nucleus such that it may not
exit and is almost completely localized in the nucleus.
The distinct subcellular distributions of NLS-
tagged huntingtin and huntingtin without NLS al-
lowed us to study the e¡ect of cellular factors on
the aggregation of huntingtin in the cytoplasm and
nucleus. The cytoplasmic aggregation of huntingtin is
found to be in£uenced by chaperones. Deletion and
overexpression of Ydj1 (a member of the Hsp40 fam-
ily), Ssa1 (a member of the Hsp70 family), and
Hsp104 in yeast show that Hsp104 deletion results
in the most striking inhibition of huntingtin aggrega-
tion [21]. Since deletion or overexpression of Hsp104
cure cells of [PSI], a prion-like form of the yeast
release factor Sup35 [24,25], the balance of chaper-
one proteins may be important for controlling the
folding of proteins. One of the possibilities is that
deletion of Hsp104 leads to altered function or ex-
pression of other cytoplasmic proteins, which in turn
inhibits huntingtin aggregation. Alternatively, the ac-
tivity of other cellular factors is important for the
suppression of huntingtin aggregates in Hsp104 dele-
tion yeast. This hypothesis is supported by the evi-
dence that only viable cells of the Hsp104 deletion
strain can prevent huntingtin aggregation and that
their extracts can inhibit the aggregation in vitro.
To date, there is no report about the existence of
Hsp104 orthologues in animals. However, the bal-
ance of other chaperone proteins in mammalian cells
has been shown to be important for regulating pro-
tein aggregation. For example, overexpression of
Hdj2/Hsdj chaperones in mammalian cells can have
Fig. 5. Extracts of Hsp104 deletion yeast cells inhibit huntingtin
aggregation. (A) His-tagged fusion protein containing the HD
exon1 protein with 120 glutamines (His-120Q) was produced
from bacteria and detected by Western blot with EM48 immu-
nostaining. (B) Bacterial lysates containing His-120Q were incu-
bated with yeast extracts at 4‡C for 1^3 days to allow aggregate
formation. Yeast extracts were prepared from wild type and
Hsp104 deletion yeast. The aggregated proteins were examined
using a ¢lter trap assay. Note that incubation of His-120Q with
yeast cytosolic extracts isolated from Hsp104 deletion strain in-
hibits the self-aggregation of His-120Q. This inhibitory e¡ect is
greater than that with wild type yeast extracts (WT), PBS bu¡-
er, BSA, or boiled extracts of Hsp104 deletion yeast cells. (C)
Quantitative assessment of the inhibitory e¡ect of extracts of
Hsp104 deletion strain on the aggregation of His-120Q by den-
sitometry. The relative value of protein aggregation represents
the percentage of the control that is the highest density of His-
120Q aggregates at 3 day incubation with PBS. Data were ob-
tained from 4^7 independent experiments and expressed as
mean+S.D. **P6 0.01 and *P6 0.05 compared with the e¡ect
of wild type yeast extracts.
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varied e¡ects: it suppresses polyglutamine aggrega-
tion in HeLa cells [9,12], does not a¡ect polyglut-
amine aggregation in a neural cell line (Neuro2a)
[14], and increases polyglutamine aggregation in
Cos-7 cells [17].
While deletion of Hsp104 inhibits the aggregation
of huntingtin in the cytoplasm, it does not prevent
the aggregation of huntingtin in the nucleus. Consis-
tently, in polyglutamine Drosophila models, overex-
pression of two chaperones (the Hsp70 and Hsp40
homologues) suppresses polyglutamine-induced neu-
rodegeneration, but has little e¡ect on intranuclear
aggregation of polyglutamine proteins [19,20]. Thus,
polyglutamine protein aggregation in the nucleus
may be independent of the cytoplasmic function of
chaperone proteins, perhaps because the distribution
and e¡ects of chaperones are relatively restricted to
the cytoplasm.
The di¡erent e¡ects of chaperones on nuclear and
cytoplasmic aggregates could contribute to the phe-
nomenon that nuclear aggregates are preferentially
formed in the nucleus in HD and other polyglut-
amine diseases [3,7,26,27]. Overexpression of chaper-
ones has been found to inhibit both polyglutamine
aggregates and cell death [9^17,28^30]. Since intra-
nuclear aggregates do not cause neurodegeneration
[31,32], the e¡ect of chaperones on the cytoplasmic
aggregation of polyglutamine proteins may be im-
portant for their neuroprotective e¡ects. It is possible
that aggregated or misfolded polyglutamine proteins
are more toxic in the cytoplasm than in the nucleus.
This idea is suggested by recent studies showing that
the development of neuropil aggregates, but not nu-
clear aggregates, is highly correlated with disease
progression in HD transgenic mice [6]. Thus, the
neuroprotective e¡ects of chaperones that have
been demonstrated in animals [19,20] may result
from their inhibition of aggregation or misfolding
of polyglutamine proteins in the cytoplasm. Under-
standing the di¡erent e¡ects of chaperones on cyto-
plasmic and nuclear aggregates will help the evalua-
tion of an e¡ective means to prevent the cytoplasmic
toxicity of polyglutamine proteins.
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